Neuropsychopharmacology and Plasticity : Advances, Mechanisms, and Translational Challenges

個数:
  • 予約

Neuropsychopharmacology and Plasticity : Advances, Mechanisms, and Translational Challenges

  • 現在予約受付中です。出版後の入荷・発送となります。
    (重要:表示されている発売日は予定となり、発売が延期、中止、生産限定品で商品確保ができないなどの理由により、ご注文をお取消しさせていただく場合がございます。予めご了承ください。)

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版
  • 商品コード 9783032460547

Full Description

Neuropsychopharmacology and Plasticity: Advances, Mechanisms, and Translational Challenges provides a comprehensive review of how pharmacological treatments intersect with neuroplasticity. Starting with a basic overview, it defines key concepts like synaptic and structural plasticity, explains their molecular foundations, and highlights primary neurotransmitter systems. The book covers both traditional and new psychopharmacological agents, offering historical background and clinical significance. A central theme is the gap between basic science and clinical application, analyzing limitations of animal models and the challenges in applying preclinical plasticity markers to human psychiatric conditions. It critically discusses methodological issues that hinder translating lab findings into effective treatments. The volume reviews methods for measuring plasticity in humans, such as PET imaging, EEG markers, and serum BDNF, noting ongoing issues with sensitivity, specificity, and consistency, especially in psychiatric populations. The effects of rapid-acting antidepressants and psychedelics like ketamine and psilocybin on structural and functional plasticity are examined, along with their potential for long-term neural changes. Chapters also explore combination drug therapies aimed at enhancing plasticity, including HDAC inhibitors and cAMP modulators, emphasizing the need for more systematic testing of these strategies. The role of individual genetic differences, like BDNF polymorphisms and methylation, is analyzed for personalized treatment approaches, raising ethical and practical questions about using genetic and epigenetic profiles. The importance of developmental windows—early life, adolescence, and aging—is discussed concerning age-specific plasticity and treatment effectiveness. The contribution of glial cells to plasticity and their potential as therapeutic targets is also included. Lastly, the volume addresses the methodological, ethical, and regulatory challenges in integrating pharmacotherapy with psychotherapy and offers insights for future clinical trial designs.

最近チェックした商品